MedTrace Logo

D-Cycloserine as an Adjunct to Internet-CBT for OCD

NCT01649895 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2016-12-12

No results posted yet for this study

Summary

The purpose of this study is to examine if D-Cycloserine is an effective adjunct to internet-based cognitive behaviour therapy for patients with obsessive-compulsive disorder.

Conditions

  • Obsessive-compulsive Disorder

Interventions

DRUG

D-Cycloserine

Predicted to enhance the effects of exposure in internet-based cognitive-behaviour therapy

DRUG

Placebo

Placebo pills as adjunct to internet-based cognitive-behaviour therapy

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Königska

    collaborator UNKNOWN

  • Region Stockholm

    collaborator OTHER_GOV

  • Christian Rück

    lead OTHER

Principal Investigators

  • Christian Rück, MD, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01649895 on ClinicalTrials.gov